Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

MEPROBAMATE vs MERCAPTOPURINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

MEPROBAMATE vs MERCAPTOPURINE: Safety Overview

Metric MEPROBAMATE MERCAPTOPURINE
Total FAERS Reports 427 11,490
Deaths Reported 320 1,468
Death Rate 74.9% 12.8%
Hospitalizations 55 5,925
Average Patient Age 44.8 yrs 21.5 yrs
% Female Patients 54.6% 43.8%
FDA Approval Date Approved Prior to Jan 1, 1982 Approved Prior to Jan 1, 1982
Manufacturer Cipla USA Inc. Florida Pharmaceutical Products, LLC
Route ORAL ORAL
Marketing Status Discontinued Prescription